5GZ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Waverley Pharma Inc

Watchlist Manager

Watchlist

Price: 0.006 EUR Market Closed

Market Cap: €503.3k

	Waverley Pharma Inc F:5GZ	CA

Profitability Summary

Waverley Pharma Inc's profitability score is 37/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

37%

Sustainable 3Y Average Gross Margin

23%

Gross Margin is Increasing

34% > 37%

Negative Operating Margin

-36%

Negative 3Y Average Operating Margin

-437%

Operating Margin is Increasing

-147% > -36%

Negative Net Margin

-50%

Negative 3Y Average Net Margin

-597%

Net Margin is Increasing

-115% > -50%

Negative Free Cash Flow Margin

-41%

Negative 3Y Average Free Cash Flow Margin

-264%

Free Cash Flow Margin is Increasing

-85% > -41%

Exceptional ROE

26%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-113%

ROIC is Increasing

-65% > -56%

View All

Hide

Collapse

37 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.